Taiwan's government will formalize plans by the end of July to allocate NT$1 billion (US$33.9 million) to hold clinical trials of COVID-19 vaccine candidates with the goal of developing an effective vaccine by the first quarter of 2021, according to the head of the Food and Drug Administration (FDA).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan to allow foreign nationals to serve in social work sector: MOL
05/03/2024 12:22 AM - Business
Taiwan's manufacturing industry could be the first to recruit Indian workers
05/03/2024 12:07 AM - Cross-Strait
Taiwan bans its citizens from working for China's Confucius Institutes
05/03/2024 12:01 AM - Business
MOTC rolls out NT$1,000 travel subsidies for Hualien post-quake recovery
05/02/2024 11:12 PM - Cross-Strait
10 PLA aircraft cross Taiwan Strait median line: Defense ministry
05/02/2024 10:39 PM